RECRUITINGOBSERVATIONAL
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
About This Trial
Objectives: 1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection. 2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis. 3. To determine the long term cognitive and physical sequelae of sepsis after admission.
Who May Be Eligible (Plain English)
Who May Qualify:
- Age 18 years or higher
- Presentation at the Emergency Department (ED)
- Clinical suspicion of infection or earlier confirmed infection
- Modified Early Warning Score (MEWS) of 2 or higher
Who Should NOT Join This Trial:
- No willing to sign a consent form given
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Age 18 years or higher
* Presentation at the Emergency Department (ED)
* Clinical suspicion of infection or earlier confirmed infection
* Modified Early Warning Score (MEWS) of 2 or higher
Exclusion Criteria:
* No informed consent given
Treatments Being Tested
OTHER
No intervention
There is no intervention
Locations (3)
Flevoziekenhuis
Almere Stad, Flevoland, Netherlands
Amsterdam UMC, location VUMC
Amsterdam, North Holland, Netherlands
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands